血管内皮细胞中ABCA1的表达及其在动脉粥样硬化发生中的意义

南方医科大学学报 ›› 2004, Vol. 24 ›› Issue (09): 980-983.

血管内皮细胞中ABCA1的表达及其在动脉粥样硬化发生中的意义

李建华, 郭志刚, 吴平生, 杨永红, 赖文岩

第一军医大学南方医院心内科, 广东, 广州, 510515

出版日期:2004-09-20 发布日期:2004-09-20
基金资助:
收稿日期:2003-10-11。
基金项目:国家自然科学基金(30171028);广东省自然科学基金(010616)
作者简介:李建华(1971-),女,1995年毕业于第四军医大学,现为第一军医大学在读博士研究生,主治医师、讲师,电话:020-61365725,E-mail:lijhlijh@126.com
通讯作者:郭志刚,电话:020-61641515

Expression of ABCA1 in vascular endothelial cells and its significance in the pathogenesis of atherosclerosis

LI Jian-hua, GUO Zhi-gang, WU Ping-sheng, YANG Yong-hong, LAI Wen-yan

第一军医大学南方医院心内科, 广东, 广州, 510515

Online:2004-09-20 Published:2004-09-20

摘要/Abstract

摘要： 目的以人的血管内皮细胞ECV304为靶点,研究Ox-LDL和8-Br-cAMP对ATP-结合盒转运子A1(ABCA1)、细胞间粘附因子-1(ICAM-1)及单核细胞趋化因子-1(MCP-1)基因mRNA和蛋白质表达的影响,阐明ABCA1基因在动脉粥样硬化(AS)形成中的可能机制。方法复苏培养血管内皮细胞,无血清培养基培养静止12 h后,分别加入Ox-LDL (30 ng/ml)、8-Br-cAMP (0.5 mmol/L)刺激3、6、12、24 h,设未加刺激同时孵育24 h的细胞为阴性对照组,以RT-PCR和Western蛋白印迹法检测ABCA1、ICAM-1及MCP-1 mRNA和蛋白质表达量。结果血管内皮细胞ECV304在给予Ox-LDL刺激后,ABCA1、ICAM-1、MCP-1的mRNA和蛋白质水平均增高,ICAM-1的高峰时间在12 h,其余高峰时间在6 h;在8-Br-cAMP的刺激下,ABCA1、ICAM-1、MCP-1的mRNA和蛋白质水平也增高,高峰时间均在6 h。结论公认的致AS因素Ox-LDL可通过引起血管内皮细胞ECV304中炎性细胞因子ICAM-1、MCP-1 mRNA及蛋白质水平增加,参与AS的形成,同时抗AS基因ABCA1在Ox-LDL刺激下代偿增加,具有AS保护作用。cAMP不仅可增加ABCA1的表达,而且可增加ICAM-1、MCP-1表达。

Abstract: Objective To investigate the changes in the expressions of ATP-binding cassette transporter A1 (ABCA1), intercellular cell adhesion molecule type 1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) at mRNA and protein levels after the treatment of the vascular endothelial ECV304 cells with oxidized low-density lipoprotein (Ox-LDL) and 8-Br-cAMP, thereby to explore possible mechanisms by which ABCA1 affects the formation of atherosclerosis (AS). Methods Resuscitated and cultured ECV304 cells were incubated in serum-free medium for 12 h to induce the quiescence phase of growth, which were subsequently treated with Ox-LDL (30 ng/ml) and 8-Br-cAMP (0.5 mmol/L) respectively for 3, 6, 12, and 24 h. After the cells were harvested at the specified time points, the mRNA and protein levels of ABCA1, ICAM-1 and MCP-1 were detected by RT-PCR and Western blotting, respectively. Results The mRNA and protein expression levels of ABCA1, ICAM-1 and MCP-1 all increased after treatments with Ox-LDL and 8-Br-cAMP. The highest expression of ICAM-1 occurred in cells with a 12-hour treatment, and those of ABCA1 and MCP-1 occurred following 6-hour incubation with Ox-LDL. The expression peaks of ABCA1, ICAM-1 and MCP-1 all took place after 6-hour incubation with 8-Br-cAMP. Conclusions The mRNA and protein expressions of ICAM-1 and MCP-1 in vascular endothelial ECV304 cells increase in response to Ox-LDL treatment, in the event of which ABCA1 is also up-regulated to offer protective effects against AS. cAMP not only enhances the expression of ABCA1 but also those of ICAM-1 and MCP-1.

中图分类号:

李建华, 郭志刚, 吴平生, 杨永红, 赖文岩. 血管内皮细胞中ABCA1的表达及其在动脉粥样硬化发生中的意义[J]. 南方医科大学学报, 2004, 24(09): 980-983.

LI Jian-hua, GUO Zhi-gang, WU Ping-sheng, YANG Yong-hong, LAI Wen-yan. Expression of ABCA1 in vascular endothelial cells and its significance in the pathogenesis of atherosclerosis[J]. Journal of Southern Medical University, 2004, 24(09): 980-983.

参考文献

[1] Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking[J]. Curr Opin Lipidol, 2002, 13(4): 373-81.
[2] Wilcox JN, Couse TL, Wade DP, et al. Localization of human ATPbinding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues[J]. Arterioscler Thromb Vasc Biol, 2001,21(3): 378-85.
[3] Panousis CG, Zuckerman SH. Interferon-γinduces downregulation of Tangier disease gene (ATP-binding-cassette transporter1) in macrophage derived foam cells[J]. Arterioscler Thromb Vasc Biol,2000, 20(6):1565-73.
[4] Simon BC, Noll B, Maisch B. Endothelial dysfunction-assessment of current status and approaches to therapy[J]. Herz, 1999, 24(1): 62-9.
[5] Reape TJ, Groot PH. Chemokines and atherosclerosis[J]. Atherosclerosis, 1999, 147(2): 213-25.
[6] Braun M, Pietsch P, Schror K, et al. Cellular adhesion molecules on vascular smooth muscle cells[J]. Cardiovasc Res, 1999, 41 (2): 395-408.
[7] Richard W, Clair ST. Pathogenesis of atherosclerosis[J]. Cardiol Rev, 1997, 6(1):14-24.
[8] Weber C, Erl W, Weber KS, et al. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions[J]. Clin Chem Lab Med, 1999, 37(3): 243-9.
[9] Cushing SD, Berliner JA, Valente AJ, et al. Minimal modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells[J]. Proc Natl Sci USA, 1990, 87(13): 5134-8.
[10] Simon BC, Noll B, Maisch B. Endothelial dysfunction-assessment of current status and approaches to therapy[J]. Herz, 1999, 24(1): 62-75.
[11] Oram JF, Lawn RM, Garvin MR, et al. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages[J]. J Biol Chem, 2000, 275(44): 34508-22.
[12] Zhou X, Engel T, Goepfert C, et al. The ATP binding cassette transporter A1 contributes to the secretion of interleukin-1 beta from macrophages but not from monocytes[J]. Biochem Biophys Res Commun, 2002, 291(30): 598-604.